Featured publication

Tracking the developments in the fields of law and economics, public policy, and business strategy.

FALL 2025

View Issue

Search Insights

Latest Insights

Article  |  March 26, 2026

Weld Failures in Forensic Engineering: Design Insights and Diagnostic Considerations

In forensic engineering, weld failures often serve as critical evidence in the investigation of structural or mechanical system breakdowns. These failures can lead to catastrophic outcomes, including structural collapse, equipment malfunction, or safety hazards. Understanding the root causes and design vulnerabilities behind weld failures is essential for accurate diagnosis and prevention.

Read More
News  |  March 16, 2026

Driving Transparency and Accountability: Saudi Arabia’s Expanding Reach in Enforcement and Disclosure

In our latest white paper, Driving Transparency and Accountability: Saudi Arabia’s Expanding Reach in Enforcement and Disclosure, Managing Director Ralph Stobwasser and Director Tarek Bleik examine Saudi Arabia’s expanding enforcement activity and evolving transparency framework. The paper analyses the Kingdom’s approach to anti-corruption enforcement and financial transparency as part of its broader governance transformation under Vision 2030.

Read More

See All Insights

Events

See All Events
featured Engagements

Eric Poer Reflects on a Historic Forensic Investigation That Drove Sweeping Reforms at Wells Fargo in the Wake of Historic Fraud Scandal 

Eric Poer, an internationally-recognized forensic accounting, investigations, and disputes expert, led the forensic accounting and data analytics team retained to support A&O Shearman in conducting an independent investigation into Wells Fargo’s sales practices—an inquiry launched in response to one of the most significant financial consumer fraud scandals in U.S. history.

Read More
View All Engagements
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com